ITGAM and neoplasm: LA1 is a small molecule agonist of CD11b that enhances the innate immune response, and in vivo targeting of CD11b activation repolarizes TAMs and inhibits tumor growth by enhancing the pro-inflammatory immune response to tumors [23,36].